Cargando…
Human Antigen-Specific Regulatory T Cells Generated by T Cell Receptor Gene Transfer
BACKGROUND: Therapies directed at augmenting regulatory T cell (Treg) activities in vivo as a systemic treatment for autoimmune disorders and transplantation may be associated with significant off-target effects, including a generalized immunosuppression that may compromise beneficial immune respons...
Autores principales: | Brusko, Todd M., Koya, Richard C., Zhu, Shirley, Lee, Michael R., Putnam, Amy L., McClymont, Stephanie A., Nishimura, Michael I., Han, Shuhong, Chang, Lung-Ji, Atkinson, Mark A., Ribas, Antoni, Bluestone, Jeffrey A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908680/ https://www.ncbi.nlm.nih.gov/pubmed/20668510 http://dx.doi.org/10.1371/journal.pone.0011726 |
Ejemplares similares
-
Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes
por: Putnam, Amy L., et al.
Publicado: (2009) -
Retinoic Acid and Rapamycin Differentially Affect and Synergistically Promote the Ex Vivo Expansion of Natural Human T Regulatory Cells
por: Golovina, Tatiana N., et al.
Publicado: (2011) -
Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer Therapy
por: Seay, Howard R., et al.
Publicado: (2016) -
Avidity and Bystander Suppressive Capacity of Human Regulatory T Cells Expressing De Novo Autoreactive T-Cell Receptors in Type 1 Diabetes
por: Yeh, Wen-I, et al.
Publicado: (2017) -
Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype In Vitro and Inhibits Type 1 Diabetes-Specific Autoreactive T Cell Responses
por: Brusko, Maigan A., et al.
Publicado: (2020)